Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DPYD |
| Upstream (Parents) |
|---|
| (<<) CD14 → DPYD |
| (<<) SERPINF1 → DPYD |
| (<<) NR3C1 → DPYD |
| Downstream (Children) |
|---|
| DPYD → PGCP (>>) |
| DPYD → CD1C (>>) |
| DPYD → LOC652637///WHAMML1 (>>) |
| DPYD → IL1R1 (>>) |
| DPYD → CD14 (>>) |
| DPYD → CETN1 (>>) |
| DPYD → CTSO (>>) |
| DPYD → MRC1L1///MRC1 (>>) |
| DPYD → ST3GAL1 (>>) |
| DPYD → TMEM100 (>>) |
| DPYD → CTSS (>>) |
| DPYD → PLCG2 (>>) |
| DPYD → XPO4 (>>) |
| DPYD → FAM110B (>>) |
| DPYD → ARSD (>>) |
| DPYD → MEIS2 (>>) |
| DPYD → DIRAS3 (>>) |
| DPYD → TBC1D9 (>>) |
| DPYD → GEMIN4 (>>) |
| DPYD → KRT18P50 (>>) |
| DPYD → BACH2 (>>) |
| DPYD → PLCL2 (>>) |
| DPYD → NR3C1 (>>) |
| DPYD → SNX10 (>>) |
| DPYD → PLEKHA6 (>>) |
| DPYD → EFNA4 (>>) |
| DPYD → CLEC10A (>>) |
